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Topical photodynamic therapy (PDT) is widely accepted as an effective treatment for superficial basal 
cell carcinoma (sBCC).  As with other non-surgical approaches, clearance and recurrence rates are higher 
following PDT than definitive surgical excision, with overall clearance at one year of approximately 76% 
being expected1.  For many patients this is a very suitable treatment approach, particularly if lesions are 
large and/or multiple or the patient is not suitable for surgery because of co-morbidities.  However, 
optimising PDT outcomes through exploration of variables in treatment parameters, such as drug and 
light delivery is a priority.   
Kessels and colleagues, report on a randomised controlled trial in which topical aminolaevulinic acid 
(ALA) PDT using a fractionated irradiation regime with a 2-hour dark interval delivered on one day was 
compared with conventional methyl aminolevulinate (MAL) PDT given as two treatments one week 
apart for sBCC2.  This research group has previously undertaken pre-clinical and clinical studies, 
indicating that high clearance rates can be achieved using this fractionated ALA PDT regime3.  The two-
fold irradiation process resulted in superior clearance rates of sBCC compared with a single continuous 
irradiation when followed up to 5 years after treatment4, supporting previous pre-clinical study 
observations4,5.  The hypothesis is that increased efficiency of PDT may be achieved due to optimising 
reoxygenation during the dark interval and through an enhanced immune response4.   
In the current study, whilst there was a suggestion of higher clearance rates of sBCC one year after the 
fractionated ALA PDT regime compared with the MAL PDT regime, this was a non-significant result 
possibly due to the sample size and power of the study.  Indeed, the fractionated ALA PDT regime 
resulted in greater side effects, notably pain.  The study arms had several variables of prodrugs, 
application time of prodrugs, light sources and irradiation regimes.  Therefore, given also that the 
differences in efficacy were non-significant, it is difficult to draw firm conclusions regarding the actual 
impact of the fractionation of irradiation per sae.   
The study was well undertaken in robust format and building on the authors track record from earlier 
studies, together indicates that a fractionated ALA PDT regime undertaken within the same day is an 
option for effective treatment of sBCC, although patients need to be advised of the risk of higher pain 
levels.  It would be most interesting to compare ALA PDT with MAL PDT both with fractionated 
irradiation as the only variable in a larger sample size.   
This is an important contribution to the literature as it highlights that there may be many ways to 
optimally deliver effective PDT.  Clinic arrangements and patient preference regarding acceptance of risk 
of discomfort with treatment and whether it is preferred to have treatment all in one longer day or to 
return for a second treatment at one week are factors to take into account.  Whilst effective, we cannot 
conclusively say that there is a conferred advantage of a fractionated regime for effective clearance of 
sBCC and it may be at the trade-off of increased side effects but having options regarding how to deliver 
effective PDT is key and this certainly warrants further study. 
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